AKT1 and hepatocellular carcinoma: In previous studies, it was confirmed as a major negative regulator of PI3K/Akt pathway as PTEN [30], which can inhibit the activation of PI3K/Akt signaling pathway in HCC cells, thus inhibiting the progression of HCC.